Medicine for Opioid Use Disorders: Considerations for Judges and Justice Stakeholders

Judge Kim McGinnis, PhD, will use her training in neuropharmacology and as a treatment court judge to dive into the neuroscience and practicalities of medicine for opioid use for justice-involved individuals. Judge McGinnis will describe how changes commonly found in the brain of people struggling with substance misuse and trauma may lead to unexpected behaviors. This will help justice stakeholders better understand why sometimes justice-involved people respond in unexpected ways to services and court requirements. The judge will explain the mechanisms of different substances of misuse and medicine for opioid use disorder. The audience will learn from a judge’s perspective how MOUD enhances outcomes and saves lives.

Neonatal Abstinence Syndrome Resources

The National Center on Substance Abuse and Child Welfare (NCSACW) is highlighting resources on best practices in the treatment of opioid use disorders and Neonatal Abstinence Syndrome. NCSACW is a national resource center providing information, expert consultation, training and technical assistance to child welfare, dependency court, and substance abuse treatment professionals to improve the safety, permanency, well-being, and recovery outcomes for children, parents, and families.

Educating Drug Courts on Medication Assisted Treatment

The National Drug Court Resource Institute, with funding from the Office of National Drug Control Policy of the White House, in collaboration with the American Academy of Addiction Psychiatry, has developed an online training curriculum that provides information on the drug court system.

SAMHSA MAT Guide for Pregnant Women with OUD

SAMHSA, in collaboration with the Administration on Children, Youth, and Families, developed this guide promoting collaborative efforts among agencies and providers serving pregnant and postpartum women with opioid dependence and their infants. This publication includes an overview of the extent of opioid use by pregnant women and evidence-based recommendations for treatment approaches from leading professional organizations.